Veru IncEquity-NMS: VERU
Equity-NMS: VERU
$0.77
+0.02
(4 Oct)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$0.77
Open
$0.77
Today’s high
$0.78
Today’s low
$0.76
52W low
$0.36
52W high
$1.92
1Y
0.90%
5Y
-18.39%
EPS (TTM)
-0.30
Shares O/S
146.38M
Market cap
112.72M
Insights
No insights found for this stock
Compare with other stock
Price
1D
PE
Market cap
About Veru Inc

Veru Inc. is a biopharmaceutical company. The Company is focused on developing medicines for the for the treatment of hospitalized COVID-19 patients at high risk for acute respiratory distress syndrome (ARDS) and other viral-related ARDS and for the management of breast and prostate cancers. The Company offers two FDA approved products within its sexual health program, including ENTADFI (tadalafil 5mg and finasteride 5mg capsule), for the treatment of benign prostatic hyperplasia and FC2 Female Condom (internal condom) (FC2), for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.

Its breast cancer drug pipeline has four clinical development programs for two drugs, such as enobosarm, an oral selective androgen receptor targeting agonist, and sabizabulin, an oral cytoskeleton disruptor. Its prostate cancer drug pipeline includes sabizabulin, VERU-100 and zuclomiphene citrate. .


FAQs

Can I buy Veru Inc shares in India?
How to buy Veru Inc shares in India?
What is the share price of Veru Inc?
What is the Market Capitalization of Veru Inc?
What is the PE ratio of Veru Inc?
Is Veru Inc a good stock to buy?
In which sector / industry does Veru Inc operate?